Technical Report
Alibaba Group Holding Limited - BABA - AI Score : 95.24%
Alibaba Group Holding Ltd. (NYSE: BABA) is trading around the $115 level, a zone that has historically served as an important support area on the chart. This price range has acted like a “pivot point,” where the stock has either bounced or broken through in the past. Whether BABA holds this level or falls below it could shape what comes next: holding support could lead to a move back toward $130–$140, while a breakdown might open the door toward $100.
Earlier this year, the stock rallied to about $140, backed by strong investor sentiment. But recent worries—particularly around U.S.–China trade tensions and global tariffs—sparked a market-wide selloff. Since then, BABA has slipped below its short-term trend lines, like the 20-day and 50-day moving averages, which often signal a loss of near-term momentum.
However, it recently found support at the 200-day moving average—a longer-term indicator many institutional investors use to track trend direction. That support helped push the stock back toward $130 briefly, before renewed uncertainty sent it back to the $115 zone. This sideways movement suggests the stock is "coiling," or moving in a tight range, waiting for a catalyst to break higher or lower.
Momentum signals are mixed. The Relative Strength Index (RSI) is at 43.59, close to “oversold” territory, which suggests the stock may be nearing a point where buyers could step in. Meanwhile, the MACD, a trend and momentum indicator, is still negative but approaching the zero line—often a sign that selling pressure may be fading.
In summary, $115 is a key level to watch. If BABA stays above it and buyers return, the stock could climb toward $130 or even retest the $140 zone. But if it falls below $115 with strong volume, a drop toward $100 becomes more likely. Investors should watch both price behavior and broader trade headlines closely to gauge direction.
JD.com, Inc. - JD - AI Score : 91.32%
JD.com, Inc. (NASDAQ: JD) has been moving sideways in a narrow range between $30 and $35 for several weeks. This type of price behavior, called a “consolidation,” often comes before a strong move in either direction. The $30 level is especially important—it's been tested multiple times without breaking, suggesting that buyers are stepping in there to provide support.
Earlier in the year, JD made a strong upward move, but global trade tensions and market uncertainty pulled it back. Since then, the stock has struggled to regain consistent upward momentum and is now trading below its short-, medium-, and long-term moving averages (20-, 50-, and 200-day). These averages often serve as reference points for market participants to judge trend strength.
Right now, JD sits just under those resistance levels, meaning it would need to rise above them to signal a potential trend reversal. If that happens, particularly with higher trading volume, it could set off a more meaningful rally.
On the momentum front, things look fairly neutral. The RSI is around 46, showing the stock isn’t overbought or oversold. The MACD is flat and near the zero line, indicating that neither buyers nor sellers currently have an edge. This balance reflects a “wait-and-see” market environment.
Historically, JD has made strong moves after long periods of low volatility like this. If the stock breaks above $35, it could move quickly toward $40—about a 20% upside from current levels. On the other hand, if it breaks below $30, the trend could reverse lower, possibly toward price levels not seen since mid-2023.
In short, JD is sitting in a key technical zone. Investors should watch closely for any breakout from the $30–$35 range, especially if supported by volume and positive sentiment around Chinese equities or trade policy.
Regeneron Pharmaceuticals, Inc. - REGN - AI Score : 85.72%
Regeneron Pharmaceuticals (NASDAQ: REGN) is showing a wide gap between its strong business fundamentals and its weaker recent stock performance. The company is financially solid, with a strong pipeline of treatments, but the stock has been under pressure—falling nearly 50% from its highs near $1,000 in late 2023.
Now trading around $520, REGN is sitting at a key area on the chart. The $500–$525 range is not just a round number—it’s also a zone where important technical levels (like the 20-, 50-, and 200-day moving averages) come together. This area has acted as both a floor (support) and ceiling (resistance) in the past, which means it could determine the next move.
Technical indicators show the stock is in a transition phase. The RSI is at 45.66, which is neutral but getting close to oversold—an area where long-term investors often look for buying opportunities. The MACD is still negative, but starting to turn up—a sign that selling pressure may be fading.
If REGN holds above $500 and broader market sentiment improves, the stock could start climbing again. A move above $525 with strong volume could lead to a rebound toward $700–$800. If confidence returns to the biotech sector, a longer-term push back toward $1,000 isn’t out of the question.
However, if the $500 support level fails and regulatory or market concerns grow, REGN could continue drifting lower. In that case, investors would want to wait for a clearer sign of bottoming before stepping in.
For now, REGN remains one of the more oversold large-cap biotech names, despite its strong business foundation. It’s a stock to watch closely as price behavior around the $500 mark could reveal the next major trend.
Merck & Co., Inc. - MRK - AI Score : 85.60%
Merck & Co. (NYSE: MRK) is a global pharmaceutical leader currently trading near the $80 mark, a key technical level that could determine whether the stock begins to recover or continues to consolidate. After trending lower since August 2024, Merck has now broken below its key moving averages—the 20-, 50-, and 200-day lines—suggesting that momentum has been soft but potentially stabilizing.
Unlike more volatile biotech stocks, Merck typically moves in steady, slower trends. It's considered a “low-beta” name, meaning it tends to fluctuate less than the broader market. The current price around $80 has become a focal point—both technically and psychologically—as investors wait to see whether the stock can regain its footing.
Technical signals are starting to show early signs of improvement. The Relative Strength Index (RSI) is currently at 48.06, near the midpoint of the range, indicating a balanced market. More importantly, the MACD indicator recently crossed above the zero line for the first time in almost a year. This type of “bullish crossover” can signal the beginning of a trend change, especially when it follows a long consolidation.
For the past several weeks, Merck has traded sideways near $80. A sustained move above this level—particularly above $82–$83 with increasing volume—could attract renewed interest and push the stock toward the $90–$100 range. On the other hand, if the stock fails to break out, it may continue trading in a narrow band or drift slightly lower toward the mid-$70s.
For long-term investors, Merck’s current level may represent an attractive entry point. It offers stability, income through dividends, and exposure to a well-diversified pharma pipeline. Investors should monitor the stock’s behavior closely around $80, as any sustained move above this zone could signal the beginning of a new upward phase.
SLB (Schlumberger Limited) - SLB - AI Score : 83.96%
SLB (NYSE: SLB), one of the world’s top oilfield services providers, is trading near $34, a level that has recently acted as both a support and resistance zone. The stock has been stuck in a downtrend for several months, reflecting broader market uncertainty around energy demand, oil prices, and global production levels.
SLB’s recent chart activity shows a series of failed breakout attempts. It remains below its key 20-day and 200-day moving averages, which suggests weak short- and long-term momentum. However, the stock is trying to hold above its 50-day moving average—often viewed as a medium-term trend signal—but has so far struggled to gain traction.
Momentum indicators provide a cautious read. The RSI is currently at 44.17, not yet in oversold territory but showing persistent weakness. The MACD is hovering just below the zero line and has attempted several bullish crossovers—when the MACD line rises above the signal line—but each attempt has faded without follow-through.
The $34–$36 range is critical. If SLB can break above $36 with strong volume, it could mark the start of a trend reversal, with a possible target near $40. However, if the stock fails to hold above $34, the next support zone appears around $30, where prior buying interest emerged.
From a valuation standpoint, SLB may look appealing to long-term investors, especially those bullish on energy infrastructure and global oil demand. But the technical picture remains cloudy. Until a clear breakout or breakdown occurs, SLB is in a holding pattern. Investors should closely monitor price action and oil sector sentiment for signals of the next move.
Toyota Motor Corporation - TM - AI Score : 83.63%
Toyota Motor Corp. (NYSE: TM), one of the world’s largest and most stable automakers, is currently trading around $175. The stock has been moving within a broad range between $150 and $200 for much of the past year, with $175 acting as a midpoint. This rangebound behavior is typical for Toyota, which generally trades in smoother, more gradual patterns rather than sharp swings.
Recently, the stock declined from the $190s to a low near $155 after the company reported operational headwinds. However, TM has since bounced back and is now stabilizing above $170. Importantly, it has begun to approach key resistance levels at $180 and $185. These levels have historically capped upward momentum, so a breakout above them would signal renewed strength.
Technically, the RSI is reading 44.42, suggesting that momentum is neutral—not overbought or oversold. The MACD, which measures trend shifts, has risen from deeply negative territory and is trending toward the zero line. This kind of movement often indicates that bearish momentum is fading and that a potential turnaround may be forming.
Toyota is currently below its 20-, 50-, and 200-day moving averages, meaning the technical backdrop still leans cautious. But if the stock can push through $185 with conviction, it could set the stage for a move toward the $200 mark.
From a long-term perspective, Toyota remains fundamentally strong, supported by its global market leadership, significant R&D investment, and steady transition toward hybrid and electric vehicles. Investors looking for stability and gradual upside may find the current range attractive—especially if the stock breaks above technical resistance.
Salesforce, Inc. - CRM - AI Score : 82.92%
Salesforce (NYSE: CRM) is currently trading near $270, following a multi-month correction from its February 2025 high of around $360. While that decline may seem steep, it largely reflects a cooling-off period after an extended rally—common among high-growth technology stocks that temporarily outpace their fundamentals.
CRM is known for its “swing-based” trading behavior—alternating between uptrends and pullbacks in well-defined cycles. These patterns can offer opportunities for both long-term investors and tactical traders. Right now, the stock appears to be stabilizing, with early signs of recovery.
Momentum indicators support this view. The RSI is at 54.86, firmly in neutral territory, while the MACD is trending higher and approaching the zero line. These signals often suggest that buying interest is returning and that selling pressure is easing.
From a technical standpoint, CRM is hovering near its 20- and 50-day moving averages. These lines often serve as key trend indicators. If the stock can move above them with strong volume, it may advance toward the 200-day moving average, which currently sits near the $300 level—a psychologically and technically important target.
On the downside, support around $250 has held firm through multiple tests, suggesting that investors view it as a floor. If CRM holds above $270 and breaks above $280, it could attract more buyers and potentially rally toward $300 in the short to medium term.
In summary, Salesforce appears to be emerging from its correction phase with improving momentum and technical structure. It offers a favorable risk-reward setup for investors looking to re-enter quality tech names at more reasonable valuations.
Edison International - EIX - AI Score : 82.37%
Edison International (NYSE: EIX), a major U.S. utility stock, has faced a slow but steady decline since early 2025. After a modest uptrend in 2024, the stock reversed course and has since been drifting lower, reflecting a combination of sector softness and a lack of strong buying momentum.
Now trading around $50, EIX is sitting near a critical support level. This area has the potential to form a “double bottom”—a chart pattern that sometimes signals the start of a rebound. Whether or not that happens will depend on whether buying interest picks up in the coming weeks.
Momentum signals are mixed. The RSI sits at 40.40, just above oversold territory, indicating that the stock is under pressure but not yet in panic-selling territory. The MACD is trending slowly toward the zero line, suggesting a possible shift in momentum, though confirmation is still lacking.
The stock has hovered near its 20-, 50-, and 200-day moving averages for most of the year. When these lines converge and flatten, it usually indicates a lack of clear trend. That’s exactly where EIX stands now—consolidating, but not yet signaling a breakout.
If EIX can hold above $50 and attract volume, it may attempt a move toward $55 or higher, especially if sentiment in the utilities sector improves. On the other hand, if $50 fails to hold, a drop toward the $47–$48 range becomes more likely.
At this stage, Edison is best viewed as a “watchlist stock” for patient investors. A positive catalyst—such as better regulatory clarity or improving sector flows—could help it build a new base and reverse higher.
Elevance Health, Inc. - ELV - AI Score : 81.92%
Elevance Health (NYSE: ELV) is currently retesting the $370 level—a price zone that has acted as a key support area in the past. Earlier this year, the stock bounced from this region and delivered a strong 20% rally before stalling near $450. Now, the stock is back at that same level, and investors are watching to see if history repeats itself.
ELV is trading just below its major moving averages (20-, 50-, and 200-day), creating a short-term technical ceiling. However, the presence of a possible “double bottom” at $370—combined with improving momentum—suggests the stock may be preparing for another attempt higher.
The RSI currently reads 43.15, a level that signals neutral-to-weak momentum, but notably close to the level where the last rally began. The MACD remains negative but is flattening, which could signal a pending shift toward positive momentum if buying pressure builds.
Volume trends also offer encouragement. ELV has a history of attracting institutional support at key levels, increasing the chances of a rebound if the technical setup strengthens.
The upside case: if ELV breaks above its 200-day moving average near $400 with strong volume, that would likely confirm a bullish reversal and could prompt a move back toward previous highs. The downside case: if $370 fails to hold, the stock could retrace toward $355 before finding new support.
Overall, ELV is at a technical crossroads. For long-term investors, this level may offer an attractive entry—provided one is willing to wait for confirmation of renewed momentum.
Omnicon Group, Inc. - OMC - AI Score : 81.44%
Omnicom Group (NYSE: OMC), a leader in advertising and marketing services, has been under steady pressure since peaking near $100 in late 2023. The stock hasn’t collapsed, but it has consistently failed to hold onto rallies, keeping it below its key moving averages for most of 2024 and into 2025.
Now trading near $70, OMC is showing signs of technical stabilization. The stock has tested this level several times without breaking lower, forming what could be a “double bottom”—a pattern that often signals a potential turnaround.
Technically, the stock is compressed in a tight range. The 20- and 50-day moving averages are starting to converge near $80. A move above this area would represent a meaningful technical shift and could lead to a push toward $90–$100 over time.
Momentum signals are cautiously constructive. The RSI is at 47.42, indicating the stock is near the lower end of its recent range, but not severely oversold. The MACD is approaching the zero line, which means momentum may be shifting from negative to positive.
OMC’s story isn’t about fast growth or major catalysts—it’s about whether sentiment is improving enough to justify re-rating a stable business model. If $70 continues to hold and the stock pushes above $80 on volume, it could begin a slow but steady recovery. If not, the downtrend may persist, albeit likely at a measured pace.
Investors looking for stability and yield may find OMC’s current levels attractive, but technical confirmation will be key before a sustained move higher can be expected.